The Effect of Vibration Application on Pain and Satisfaction Associated With Subcutaneous Anticoagulation Injection
1 other identifier
interventional
85
1 country
1
Brief Summary
This study was needed to relieve the pain associated with subcutaneous injection, which is an application performed by nurses, to increase patient satisfaction, to increase patient compliance with treatment, and to strengthen positive patient-nurse communication. The purpose of this study is to assess the effect of vibration stimulation application on subcutan injection induced pain and patient satisfaction. The study will be carried out in the internal medicine service of a university hospital. Vibration will be applied during subcutaneous injection of anticoagulant to one group, but not to the other group. It was planned to include 85 patients in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pain
Started Sep 2022
Shorter than P25 for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 20, 2022
CompletedFirst Submitted
Initial submission to the registry
December 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2023
CompletedFirst Posted
Study publicly available on registry
January 17, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2023
CompletedJanuary 17, 2023
January 1, 2023
4 months
December 30, 2022
January 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Patient Information Form
It includes some socio-demographic characteristics of the individual (age, gender, place of residence, marital status, educational status, employment status).
day 1
Visual Analog Scale
Scale, 10 cm long, horizontal or vertical; It consists of a line starting with "No Pain" and ending with "Unbearable Pain". The use of VAS should be explained to the patient very well. The patient is asked to indicate the severity of the pain with a sign on this line where he deems appropriate. The distance between the onset of no pain and this point is measured in cm and recorded. Values range from 0 to 10, and patients' pain levels are evaluated over 10 points as 0 = no pain, 10 = unbearable pain.
day 1
Visual Analog Scale
Scale, 10 cm long, horizontal or vertical; It consists of a line starting with "No Pain" and ending with "Unbearable Pain". The use of VAS should be explained to the patient very well. The patient is asked to indicate the severity of the pain with a sign on this line where he deems appropriate. The distance between the onset of no pain and this point is measured in cm and recorded. Values range from 0 to 10, and patients' pain levels are evaluated over 10 points as 0 = no pain, 10 = unbearable pain.
day 2
Visual Patient Satisfaction Scale
The visual patient satisfaction scale combines with the features of the well-known VAS (Visual Analogue Scale). It consists of a 100 mm horizontal line without numbers. At one end of the line is the phrase "I am not satisfied at all" and at the other end is the statement "Very satisfied". The patient must synthesize all the components that affect him in relation to the medical care given, determine the state of satisfaction he is in and find the point on the line that corresponds to his situation.
day 1
Visual Patient Satisfaction Scale
The visual patient satisfaction scale combines with the features of the well-known VAS (Visual Analogue Scale). It consists of a 100 mm horizontal line without numbers. At one end of the line is the phrase "I am not satisfied at all" and at the other end is the statement "Very satisfied". The patient must synthesize all the components that affect him in relation to the medical care given, determine the state of satisfaction he is in and find the point on the line that corresponds to his situation.
day 2
Study Arms (2)
Intervention
EXPERIMENTALVibration will be applied to the injection site for 5 minutes before the procedure.
Control
NO INTERVENTIONNo application will be made
Interventions
The device used for vibration application is produced to control pain and direct attention by providing 6000/min vibration. According to Melzack and Wall's Gate Control Theory, the application of local vibration reduces perceived pain by stimulating nerve fibers. Therefore, it should be ensured that the device is in full contact with the skin. The device can be used again by wiping with 70% alcohol. The device is placed 3 cm above the area to be injected. Vibration is applied to the area for 5 minutes before the procedure.
Eligibility Criteria
You may qualify if:
- Volunteers aged 18 and over,
- are conscious and have no communication problems,
- body mass index (BMI) of 18.5 to 30kg/m2,
- who have not had an injection in the last two weeks in the area to be injected subcutaneously,
- no signs of skin pain, hematoma, necrosis, scarring, incision or infection at the subcutaneous injection site,
- patients treated with subcutaneous heparin injection therapy
You may not qualify if:
- patients not receiving heparin injection therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Aydin University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- All of the outcomes results were obtained by another researcher blinded to group allocation
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Prof.
Study Record Dates
First Submitted
December 30, 2022
First Posted
January 17, 2023
Study Start
September 20, 2022
Primary Completion
January 15, 2023
Study Completion
January 30, 2023
Last Updated
January 17, 2023
Record last verified: 2023-01